...
首页> 外文期刊>Central European Journal of Urology: The Polish Journal of Urology >Squamous cell carcinoma of the prostate following treatment with an LHRH–agonist: a rare case of transformation of adenocarcinoma of the prostate
【24h】

Squamous cell carcinoma of the prostate following treatment with an LHRH–agonist: a rare case of transformation of adenocarcinoma of the prostate

机译:LHRH-激动剂治疗后的前列腺鳞状细胞癌:罕见的前列腺腺癌转化病例

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Squamous cell carcinoma (SCC) is a rare variant of prostate cancer. We report a case of a patientwho was diagnosed with metastatic adenocarcinoma of the prostate, treated with leuprorelin andsubsequently found to have SCC 18 months later. We have found one case in the literature witha similar scenario of possible transformation of adenocarcinoma to SCC secondary to luteinizinghormone–releasing hormone (LHRH) treatment. We found interesting similarities between the twocases, which raise the possibility of the transformation of tumour type and highlights the importanceof the clinical picture in the follow–up, even with low prostate specific antigen (PSA) value.
机译:鳞状细胞癌(SCC)是前列腺癌的一种罕见变体。我们报告了一例患者,该患者被诊断出患有前列腺转移性腺癌,接受了亮丙瑞林治疗,随后在18个月后发现患有SCC。我们在文献中发现了一个案例,该案例与黄体化激素释放激素(LHRH)治疗继发的腺癌可能转化为SCC的情况相似。我们发现这两种情况之间有趣的相似性,这增加了肿瘤类型转化的可能性,并强调了即使随访时前列腺特异性抗原(PSA)值较低,临床影像在随访中的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号